Note: Ingredients listed on restricted chemical lists
EC/CAS
1314-13-2
Name of the chemical
Zinc oxide; C.I. 77947
Concentration
0.1
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
0.1
General Information
Version
3
Revision date
2025-04-17
Product name
Naproxen Sodium Capsules 220mg BK000437
1.2.1 Relevant identified uses
Analgesic - Internal
supplier name
PL Developments
Icons in SDS
Company Information
company name
PL Developments
e-mail address of the competent person responsible for the Safety Data Sheet
QA-CRR@pldevelopments.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Classification Acute toxicity - Oral Category 4 Appearance Blue green Physical state Solid containing liquid Odor Odorless Solid
2.2 Label elements
Warning
Hazard statements
Harmful if swallowed
Prevention
Wash face, hands and any exposed skin thoroughly after handling Do not eat, drink or smoke when using this product
Response
Ingestion IF SWALLOWED: Call a POISON CENTER or doctor if you feel unwell Rinse mouth
Precautionary statements
Disposal Dispose of contents/container to an approved waste disposal plant
Further information
Unknown acute toxicity 33.4 % of the mixture consists of ingredient(s) of unknown toxicity 33.4 % of the mixture consists of ingredient(s) of unknown acute oral toxicity 33.4 % of the mixture consists of ingredient(s) of unknown acute dermal toxicity 33.4 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (gas) 33.4 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (vapor) 33.4 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (dust/mist)
2.1 Classification of the substance or mixture
Acute toxicity - Oral Category 4 Appearance Blue green Physical state Solid containing liquid Odor Odorless Solid
